TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
IVVD

Invivyd Inc.

Healthcare · Biotechnology

0.7286$ -9.6% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Invivyd Inc. (IVVD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 219 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IVVD
Line item Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – 117 95 398 686 620 556 485 425 383 351 315 275 229 215 177 162 130 104 89 139 277 242 219
– – 117 95 396 680 617 554 481 422 377 345 310 270 225 210 173 151 101 76 59 110 247 205 182
– – 115 91 393 478 542 532 475 278 92 126 122 182 201 189 148 107 69 48 35 85 227 184 160
– – 115 91 393 666 591 532 475 419 372 333 298 265 201 189 148 107 69 48 35 85 227 184 160
– – – – – 0.7 0.2 – – 0.8 0.4 0.5 0.5 0.7 0.9 0.9 3.5 8.6 11 8.8 8.8 9.9 15 12 11
– – – – – 13 – – – – -0.4 -0.5 -0.5 -0.7 – 0.1 5.3 27 26 0.4 0.4 0.4 0.3 25 0.3
– – – – – – 0.1 1.7 3.0 1.4 2.3 2.3 2.1 – – – – – – – – – – – –
– – 183 198 543 53 62 97 70 47 27 24 34 28 52 37 37 79 62 50 46 46 35 39 38
– – 13 29 38 53 62 96 68 46 25 22 33 27 50 36 37 79 62 50 44 44 34 32 31
– – – – – – – 0.3 1.0 0.3 1.6 1.6 1.6 1.6 1.4 1.1 0.7 1.4 1.3 0.9 1.1 1.1 1.3 1.6 1.6
– – 8.2 11 11 18 5.8 19 14 17 1.5 5.9 4.1 9.2 8.0 1.2 7.5 18 10 8.7 18 18 14 2.0 9.5
– – -65 -103 -145 633 558 459 415 377 356 327 282 246 177 178 141 83 68 54 43 93 242 203 181
– – -65 -104 -149 -209 -292 -393 -444 -489 -533 -569 -619 -658 -732 -776 -823 -884 -902 -918 -933 -943 -954 -996 -1,040
21 63 5.6 63 108 61 43 108 108 108 109 109 109 110 110 116 119 119 119 120 120 170 172 310 320

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?